Terms: = Gastric cancer AND CDX2, CDX3, 1045, ENSG00000165556, Q99626 AND Clinical Outcome
5 results:
1. Prognostic significance of cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures.
Wang XT; Wei WY; Kong FB; Lian C; Luo W; Xiao Q; Xie YB
J Exp Clin Cancer Res; 2012 Nov; 31(1):98. PubMed ID: 23181722
[TBL] [Abstract] [Full Text] [Related]
2. Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are ≥1.0 cm): clinicopathologic and immunohistochemical analysis of 123 cases.
Adsay V; Jang KT; Roa JC; Dursun N; Ohike N; Bagci P; Basturk O; Bandyopadhyay S; Cheng JD; Sarmiento JM; Escalona OT; Goodman M; Kong SY; Terry P
Am J Surg Pathol; 2012 Sep; 36(9):1279-301. PubMed ID: 22895264
[TBL] [Abstract] [Full Text] [Related]
3. Mucinous gastric cancer presents with more advanced tumor stage and weaker β-catenin expression than nonmucinous cancer.
Choi MG; Sung CO; Noh JH; Kim KM; Sohn TS; Kim S; Bae JM
Ann Surg Oncol; 2010 Nov; 17(11):3053-8. PubMed ID: 20645013
[TBL] [Abstract] [Full Text] [Related]
4. Expression of the caudal-type homeodomain transcription factor cdx2 is related to clinical outcome in biliary tract carcinoma.
Chang YT; Hsu C; Jeng YM; Chang MC; Wei SC; Wong JM
J Gastroenterol Hepatol; 2007 Mar; 22(3):389-94. PubMed ID: 17295772
[TBL] [Abstract] [Full Text] [Related]
5. cdx2 expression is increased in gastric cancers with less invasiveness and intestinal mucin phenotype.
Ha Kim G; Am Song G; Youn Park D; Han Lee S; Hyun Lee D; Oh Kim T; Jae Jo H; Heo J; Hwan Kang D; Cho M
Scand J Gastroenterol; 2006 Aug; 41(8):880-6. PubMed ID: 16803685
[TBL] [Abstract] [Full Text] [Related]